AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $548,000 | +0.4% | 14,465 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $546,000 | +109.2% | 14,465 | -2.3% | 0.01% | +100.0% |
| Q2 2016 | $261,000 | +45.0% | 14,809 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $180,000 | -78.9% | 14,809 | -57.7% | 0.00% | -75.0% |
| Q4 2015 | $853,000 | +16.5% | 35,013 | -15.2% | 0.01% | +20.0% |
| Q3 2015 | $732,000 | +0.4% | 41,290 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $729,000 | -39.5% | 41,290 | +7.4% | 0.01% | -38.5% |
| Q1 2015 | $1,205,000 | -46.2% | 38,441 | -49.9% | 0.01% | -43.5% |
| Q4 2014 | $2,241,000 | +17.3% | 76,787 | -16.8% | 0.02% | +15.0% |
| Q3 2014 | $1,910,000 | -15.9% | 92,326 | +0.7% | 0.02% | -9.1% |
| Q2 2014 | $2,270,000 | +13.7% | 91,647 | -2.7% | 0.02% | +15.8% |
| Q1 2014 | $1,996,000 | -36.5% | 94,188 | -46.2% | 0.02% | -38.7% |
| Q4 2013 | $3,143,000 | – | 175,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |